GLP1R and obesity disorder: The substantial weight loss achieved from bariatric surgery or GLP-1 receptor agonists is often associated with significantly decreased energy intake, as is also the case with very low-calorie or semi-starvation diets (< 800 kcal/day) in the medical management of obesity [10, 11].